Tag: Hyloris Pharmaceuticals
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
Featured Article
Beyond Insights: Building trust into digital transformation technologies
Digital transformation technologies are experiencing a gold rush in the manufacturing industry, not just in Australia but beyond. However, amid this surge in cutting-edge tech and automation processes, a fundamental element remains crucial: trust.
